-+ 0.00%
-+ 0.00%
-+ 0.00%

Solventum Wins FDA Clearance for Combined Use of Restrata Matrix and V.A.C. Therapy

PUBT·10/19/2026 20:08:58
Listen to the news
Solventum Wins FDA Clearance for Combined Use of Restrata Matrix and V.A.C. Therapy
  • Solventum received FDA 510(k) clearance for combined use of Restrata Matrix and V.A.C. Therapy for wound healing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solventum Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG74883) on October 19, 2026, and is solely responsible for the information contained therein.